Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.
about
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumorsDCVax®-L--developed by Northwest BiotherapeuticsEffective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.Immunotherapy of brain cancers: the past, the present, and future directions.All in the head: obstacles for immune rejection of brain tumours.Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.Glioma stem cell research for the development of immunotherapy.Vaccines for glioblastoma and high-grade glioma.Immunotherapy with dendritic cells loaded with glioblastoma stem cells: from preclinical to clinical studies.Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-beta gene vector and dendritic cells.Functional heterogeneity among bone marrow-derived dendritic cells conditioned by T(h)1- and T(h)2-biasing cytokines for the generation of allogeneic cytotoxic T lymphocytes.
P2860
Q24801526-AF486898-83E2-40FB-9F00-A4B65FCACFEDQ30875456-EBE74EC5-DD0B-4085-B675-4E73E1CE2FF7Q33744525-3B88E1B4-19AC-4FF5-AD87-21D503627C17Q34423229-99263893-F726-49EF-A642-BC73984BF86FQ34701587-211C93C4-1C24-4015-97C3-5C8EE99935CFQ34842204-B3A8EC29-D7DC-4029-A72A-E61408CE9445Q35113661-7B150815-13E4-41AB-B5E3-1A4A28D1BA02Q35602700-3AF0D810-30EA-45E1-B1B2-A16E073FFE08Q36610286-6DF25913-F15C-4952-91A2-10C446E4C18DQ37452665-6484DAAA-A8BE-47B9-A22A-FD95C3A3E253Q37892597-D3185C0C-BA88-4181-93B6-89E3EB5C96EFQ38588141-BD3C0626-2B3C-4183-B243-DF1BE1E5DC8EQ40434909-D27F6030-08C2-4FC5-A1E0-2B0652B8FBA3Q40485606-95747ABF-9CEB-4003-9A06-7638C920D80CQ43115465-FA7C6049-F4E7-4B4E-8177-1440192A9583Q45348994-7DF0C989-CA9F-44AC-AF40-0EBCAAFA3C49Q45879265-0FEDC90D-99DB-4FB2-B468-4276A53A33BBQ47794847-010EC112-27BA-48AC-88A3-A28AE5303436Q52919703-0D6A6448-410C-4B95-B0A9-3B67F5503B74
P2860
Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Bone marrow-derived dendritic ...... gainst intracranial neoplasms.
@en
type
label
Bone marrow-derived dendritic ...... gainst intracranial neoplasms.
@en
prefLabel
Bone marrow-derived dendritic ...... gainst intracranial neoplasms.
@en
P2093
P2860
P1476
Bone marrow-derived dendritic ...... gainst intracranial neoplasms.
@en
P2093
J Attanucci
K M Giezeman-Smits
M R Shurin
W H Chambers
W K Fellows
P2860
P304
P356
10.1002/(SICI)1097-0215(19981005)78:2<196::AID-IJC13>3.0.CO;2-9
P577
1998-10-01T00:00:00Z